Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.
Tag: Rutgers Cancer Institute of New Jersey
Expert Available for Comment on Black Women, Breast Cancer and Clinical Trials
While there has been an overall decline in breast cancer deaths over the last 30 years, there is a persistent and significant mortality gap between Black women and white women. Black women are also disproportionately affected by more aggressive subtypes of…
Enhancing Awareness and Participation of Black Breast Cancer Patients in Clinical Trials
Coral Omene, MD, PhD, medical oncologist in the Stacy Goldstein Breast Cancer Center at Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute (NCI)-designated Comprehensive Cancer Center together with RWJBarnabas Health, has been awarded a $50,000 grant from the V Foundation for Cancer Research in partnership with ESPN to increase clinical trial awareness and enrollment of Black women with breast cancer.
Addressing the Unique Needs of LGBTQ+ Cancer Patients
June marks Pride Month when we honor the diversity, strength, and resilience of the LGBTQ+ community. We must also call to attention the healthcare challenges and barriers faced by this community.
Extensive Research Underway to Address Cancer Disparities
To highlight the importance of lifesaving cancer research, National Cancer Research Month, led by the American Association for Cancer Research (AACR), is recognized during May. Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, has curated a selection of ongoing research focusing on cancer disparities which features members from the Cancer Health Equity Center of Excellence.
5 Tips to Boost Bladder Health
Saum Ghodoussipour, MD, urologic oncologist and director of the Bladder and Urothelial Cancer Program at Rutgers Cancer Institute and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more on bladder health.
Noninvasive Brain Tumor Treatment Allows Physicians to treat tumors with Pinpoint Accuracy
Joseph P. Weiner, MD, radiation oncologist at Rutgers Cancer Institute and assistant professor of radiation oncology at Rutgers Robert Wood Johnson Medical School, who specializes in malignant and benign cancers of the brain and spine shares more about Gamma knife, a non-surgical treatment option that uses high doses of precisely focused radiation beams to destroy cancer cells and non-cancerous tumors.
Exploring Sun Protection Behaviors among U.S. Hispanic Outdoor Workers
Carolyn J. Heckman, PhD, co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is corresponding author and shares more on unburns and sun protection behaviors among male Hispanic outdoor day laborers in the Northeast U.S.
How Common is Skin Cancer? And More Questions You’re Afraid to Ask
Sarah Weiss, MD, medical oncologist at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, answers questions about skin cancer and sun protection that you may be wondering
Rutgers Cancer Institute of New Jersey Nurses to Share Knowledge and Best Practices during 47th Annual Oncology Nursing Society Congress
Oncology Nurses from Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health will be presenting at the Oncology Nursing Society’s (ONS) 47th Annual Congress being held April 27 to May 1 in Anaheim, California.
Pancreatic Cysts, Cancer and Awareness: Answers from an Expert
Russell Langan, MD, surgical oncologist at Rutgers Cancer Institute of New Jersey, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center (SBMC) and assistant professor of surgery at Rutgers Robert Wood Johnson Medical School, shares more information on monitoring pancreatic cysts and pancreatic cancer.
Confronting Disparities in Lung Cancer
Compared with all other racial and ethnic groups in the United States, Black people are disproportionally more affected by lung cancer. Sharon R. Pine, PhD, a resident member of Rutgers Cancer Institute of New Jersey, associate professor of Pharmacology and Medicine at Rutgers Robert Wood Johnson Medical School and member of the Cancer Health Equity Center of Excellence e, discusses the barriers that Black people face, the research being done on racial health disparities and how action can be taken now.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Launch State’s First Home Infusion Program
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have partnered with Horizon Blue Cross Blue Shield of New Jersey to launch a collaborative pilot program which provides oncology care to eligible patients in the comfort of their own home – the first of its kind in the state.
Rutgers Cancer Institute Research: Abdominal Fat Linked to Worse Outcomes for Black Breast Cancer Survivors
Findings from a recent population based cohort study published online in JAMA Oncology show that Black women diagnosed with breast cancer who also have central obesity, which means excess body fat in the abdominal area, were more likely to die from breast cancer or any other cause than similar women who didn’t have central obesity.
A Consensus View: Proton Therapy for Breast Cancer
Bruce Haffty, MD, MS, chair of Radiation Oncology and associate vice chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey, shares insight on proton therapy, a unique type of radiation treatment, for breast cancer.
Exploring the Impact of Blood Clots in the Veins during Renal Cell Carcinoma Surgery
Research Results from Rutgers Cancer Institute of New Jersey Presented at American Urological Association Annual Meeting
Five Facts about Thyroid Cancer
It’s thyroid cancer awareness month. Amanda M. Laird, MD, FACS, chief of endocrine surgery at Rutgers Cancer Institute of New Jersey and associate professor of surgery at Rutgers Robert Wood Johnson Medical School, shares five facts about thyroid cancer everyone should know.
Blood Cancer Cures and Care: Addressing Leukemia and Lymphoma
Kevin David, MD the director of the lymphoma program and a hematologist/oncologist at Rutgers Cancer Institute of New Jersey shares information about leukemias and lymphomas for blood cancer awareness month.
Advancements in Prostate Cancer Treatments are Providing Better Outcomes for Men
Over the last decade, advancements have been made in the diagnosis and treatment of prostate cancer that are saving more lives. Tina Mayer, MD, a medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey shares some insight.
Understanding Good Prostate Health for Cancer Prevention
Tina Mayer, MD, medical oncologist in the Prostate Cancer Program at Rutgers Cancer Institute of New Jersey and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares information about prostate health.
New Chief of Thoracic and Head and Neck Medical Oncology Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Expanding its multidisciplinary teams of highly specialized experts uniquely focused on the management of head and neck cancers and cancer of the lung, pleura and mediastinum, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have welcomed Missak Haigentz, Jr., MD, as chief of Thoracic and Head and Neck Medical Oncology and clinical director for Oncology Integration.
Mechanism for Development of Rare Colorectal Cancer Subtype Identified
Researchers from Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, recently discovered a mechanism to explain what drives the formation of mucinous colorectal adenocarcinoma (MAC), a rare subtype of colorectal cancer.
Rutgers Cancer Institute of New Jersey Expert Available for Comment on Disparities in Triple-Negative Breast Cancer
New Brunswick, N.J., August 24 2021 – Cancer is a disease that can impact anyone, but it does not impact everyone equally. According to the American Cancer Society, breast cancer is the most commonly diagnosed cancer among Black women, and Black women…
Rutgers Cancer Institute of New Jersey Expert Available for Comment on Proton Therapy for Breast Cancer
New Brunswick, N.J., August 23, 2021 – Proton therapy is a type of radiation therapy treatment that targets a tumor in a very precise way, emerging as a unique modality for breast cancer due to the ability to minimize exposure surrounding healthy…
Grief and Loss for cancer patients in the Era of COVID
The COVID-19 pandemic has brought a time period of grief in many forms, even grief unrelated to the loss of life – some caused by the need for isolation measures to slow the spread of the virus.
Palliative Care for Cancer Patients: How does it Help?
For cancer patients undergoing treatments, palliative care can provide excellent pain and symptom management that can help them feel better. Palliative care experts at Rutgers Cancer Institute of New Jersey
answer common questions about how palliative care can enhance quality of life for patients to highlight palliative care and cancer pain awareness month.
Palliative Care for Cancer Patients: How does it Help?
For cancer patients undergoing treatments, palliative care can provide excellent pain and symptom management that can help them feel better. Palliative care experts at Rutgers Cancer Institute of New Jersey
answer common questions about how palliative care can enhance quality of life for patients to highlight palliative care and cancer pain awareness month.
Check your Health: Sun Safety & Learning your ABCDE’s
Rutgers Cancer Institute of New Jersey expert shares how to check for skin cancer.
Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Radiation Oncology
Dr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.
Protecting your Heart Before, During and After Cancer Treatment
Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Leader Recognized as NJBIZ 2021 Healthcare Hero
Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category.
Frequently Asked Questions on Staying Safe in the Sun
Ultraviolet rays from the sun can be harmful and damaging to our skin. While skin cancer can be detrimental, it is also highly preventable. Skin cancer expert from Rutgers Cancer Institute answers common questions to protect yourself from the sun.
Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development
Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School (NJMS) and the Center for Theoretical Biological Physics (CTBP) at Rice University in Houston, Texas, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.
Experts from Rutgers Cancer Institute of New Jersey Comment on Lifestyle Changes for Cancer Prevention
New Brunswick, N.J., June 28, 2021 – According to the American Cancer Society, cancer is the second leading cause of death among Americans. Researchers believe that one way to decrease the risk of developing cancer is adopting a healthy lifestyle.…
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Break Ground on Jack & Sheryl Morris Cancer Center
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation (DEVCO), broke ground on the state’s first freestanding cancer hospital.
Rutgers Cancer Institute researchers shortlisted for Cancer Grand Challenges funding
A diverse, global team of scientists led by a Rutgers Cancer Institute of New Jersey leader has been selected for the final stages of Cancer Grand Challenges – with a chance of securing a share of $111 million in funding to take on one of cancer’s toughest problems.
Pride, Progress and Breaking down Barriers: LGBTQ+ Cancer Concerns
A person with cancer who identifies as lesbian, gay, bisexual, transgender or non-binary may have unique concerns about communicating with their cancer care team, navigating the healthcare system and coping with their diagnosis. An expert from Rutgers Cancer Institute calls attention to the healthcare challenges and barriers faced by this community during Pride Month and explains how health care professionals are becoming better allies.
Identifying Potential Treatment for Triple Negative Breast Cancer
Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) recently discovered a phage display-based approach to halt tumor growth that could be used to treat triple-negative breast cancer – considered the most aggressive type of breast cancer. The findings were published online in the scientific journal eLife.
The Unique Role of the Oncology Nurse: Lifelong Learning, Healing and Helping
Oncology nursing is a unique specialty that requires specific knowledge of the biological and psychosocial dimensions of cancer and its effects on individuals and families. Oncology nurse at Rutgers Cancer Institute of New Jersey shares more on the role of oncology nurses and the importance of the oncology nurse certification.
Understanding Brain Tumors
To better understand brain cancer, neuro-oncologist Michael E. Salacz, MD, director of the Neuro-Oncology Program at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some basic information on types of brain tumors, risk factors and treatment options.
The Greatest Gift for Mom: Health and Wellness
Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.
What is Bladder Cancer?
The bladder, a part of the urinary system, is a hollow organ in the pelvis with the primary function of storing and then eliminating urine that drains into it from the kidney. Cancer of the bladder develops when abnormal cells in the bladder start to grow out of control. Rutgers Cancer Institute expert explains what you need to know.
Rutgers Cancer Institute of New Jersey Experts Available for Comment on Research Topics during National Cancer Research Month
New Brunswick, N.J., April 29, 2021 – Many years of research devoted to cancer has led to valuable insight and life-saving measures. To highlight the importance of lifesaving research to the millions of people around the world impacted by cancer,…
Experts from Rutgers Cancer Institute of New Jersey Comment on Skin Cancer and Sun Protection
New Brunswick, N.J., April 29, 2021 – According to the National Cancer Institute (NCI), skin cancer is the most common type of cancer. While we all want to enjoy the outdoors, increased exposure to ultraviolet (UV) rays from the sun…
Tanning Beds and Skin Cancer: Heeding the Call to Action
Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning. Researchers at Rutgers Cancer Institute of New Jersey recently addressed the importance of increasing efforts to limit indoor tanning among minors in a viewpoint paper published in the April 28 2021 online edition of JAMA Dermatology.
Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences
Rutgers Cancer Institute of New Jersey Deputy Director, Chief Scientific Officer, and Associate Director for Basic Research Eileen White, PhD, has been elected to the National Academy of Sciences (NAS). She is among 120 members elected this year in recognition of their distinguished and continuing achievements in original research.
$9 Million Contract from National Cancer Institute Awarded for NJ State Cancer Registry
The New Jersey State Cancer Registry (NJSCR), under the direction of the State Department of Health in partnership with Rutgers Cancer Institute of New Jersey, has been awarded a seven-year, $9,085,109 contract (75N91021D00009) from the National Cancer Institute (NCI) to support core infrastructure and research activities as part of the Surveillance, Epidemiology, and End Results (SEER) Program, the most authoritative source of information on cancer incidence and survival in the United States. The funding will support ongoing cancer surveillance activities at the NJSCR, as well as support enhancements to New Jersey’s electronic reporting systems such as electronic pathology and medical claims data transmissions.
Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Clinical Oncology
Rutgers Cancer Institute of New Jersey Associate Chief of Urology and Urologic Oncology and Director of the Kidney Cancer Program Eric A. Singer, MD, MA, MS, FACS, has been named a Fellow of the American Society of Clinical Oncology (FASCO). This distinction honors members for their extraordinary volunteer service and dedication to the American Society of Clinical Oncology (ASCO).
Rutgers Cancer Institute of New Jersey Awarded $1.3M for Cancer Metabolism and Growth Research Program
Rutgers Cancer Institute has received a $1.3 million, five-year grant from the National Cancer Institute to support the Cancer Metabolism and Growth and Tumor Host Interactions Training Program which will provide postdoctoral candidates the highest quality training and research experience.
With Testicular Cancer, Being Proactive is Key
To highlight testicular cancer awareness month, an expert from Rutgers Cancer Institute of New Jersey addresses the basics of testicular cancer and the importance of self checks and talking to your doctor.